Curcumin polymers as anticancer prodrugs

Youqing Shen,Huadong Tang,Bo Zhang,Caitlin Jean Murphy,Jianbin Tang,Edward Alva Van Kirk,William James Murdoch,Maciej Radosz
2009-01-01
Abstract:Curcumin is a polyphenol showing good pharmacological safety and in vitro efficacies for various human diseases, but it has not yet been approved as a drug because of its poor bioavailability, which is a result of its water-insolubility and instability. Herein, we report a novel backone-type curcumin-conjugate - curcumin-derived high molecular weight polymers (polycurcumins) using curcumin as a comonomer. The polycurcumins have many advantages including high curcumin-loading content and efficiency, tailored water-solubility, no premature burst release, excellent stability, and adjustable hydrolysis kinetics. They have a wide range of potential applications, and their antitumor activities were particularly investigated in this paper. A polycurcumin linked with acetal bonds is highly cytotoxic to SKOV-3 ovarian, MCF-7 and OVCAR breast cancer cells. It arrests the SKOV-3 cell cycle at the G 0/G 1 phase in vitro and induced cell apoptosis partially through the caspase-3 dependent pathway. In vivo, the polymer shows remarkable antitumor activity in an intraperitoneal SKOV-3 cell-xenograft animal model.
What problem does this paper attempt to address?